Titan Biotech Limited (TITANBIO.BO)
INR 781.0
(1.07%)
INR 781.0
(1.07%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.64 Billion | 1.43 Billion | 1.52 Billion | 1.42 Billion | 794.37 Million | 649.08 Million |
| Cost of Revenue | 756.06 Million | 698.73 Million | 748.76 Million | 752.83 Million | 476.37 Million | 403.73 Million |
| Gross Profit | 884.66 Million | 741.26 Million | 779.33 Million | 669.53 Million | 318 Million | 245.34 Million |
| Operating Expenses | 117.05 Million | 472.07 Million | 394.75 Million | 225.79 Million | 200.6 Million | 171.41 Million |
| Selling, General and Administrative Expenses | 99.57 Million | 94.24 Million | 81.13 Million | 57.85 Million | 46.33 Million | 39.26 Million |
| Research and Development Expenses | - | 967 Thousand | 1 Million | 408.2 Thousand | 460.58 Thousand | 346.15 Thousand |
| Other Expenses | 17.48 Million | 19.43 Million | 10.22 Million | 1.3 Million | 258.72 Thousand | 126.71 Thousand |
| Cost and Expenses | 1.32 Billion | 1.17 Billion | 1.14 Billion | 978.63 Million | 676.97 Million | 575.14 Million |
| Operating Income | 315.89 Million | 274.25 Million | 292.44 Million | 438.42 Million | 116.82 Million | 72.12 Million |
| Interest Expense | 11.7 Million | 7.45 Million | 12.82 Million | 14.79 Million | 20.61 Million | 21.69 Million |
| Income Tax Expense | 78.65 Million | 70.92 Million | 96.45 Million | 110 Million | 25.66 Million | 16.31 Million |
| Earnings before Tax | 315.29 Million | 281.16 Million | 381.98 Million | 427.05 Million | 104.04 Million | 55.44 Million |
| Net Income | 248.53 Million | 248.44 Million | 216.84 Million | 303.35 Million | 70.65 Million | 35.22 Million |
| Earnings Per Share Basic | 30.07 | 30.06 | 26.24 | 36.71 | 8.55 | 4.26 |
| Earnings Per Share Diluted | 30.07 | 30.06 | 26.24 | 36.71 | 8.55 | 4.26 |
| Weighted Average Shares Outstanding | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million |
| Gross Margin | 0.54 | 0.51 | 0.51 | 0.47 | 0.40 | 0.38 |
| EBIT Margin | 0.22 | 0.22 | 0.27 | 0.33 | 0.17 | 0.15 |
| Profit Margin | 0.15 | 0.17 | 0.14 | 0.21 | 0.09 | 0.05 |
| EBITDA | 360.29 Million | 314.62 Million | 322.1 Million | 464.02 Million | 145.43 Million | 95.48 Million |
| Earnings Before Tax Margin | 0.19 | 0.19 | 0.19 | 0.31 | 0.15 | 0.11 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 431.14 Million | 399.18 Million | 1.64 Billion | 459.78 Million | 434.27 Million | 347.47 Million |
| Cost of Revenue | 290.85 Million | 259.29 Million | 1.02 Billion | 215.32 Million | 212.22 Million | 145.66 Million |
| Gross Profit | 140.29 Million | 139.88 Million | 614.24 Million | 244.46 Million | 222.05 Million | 201.81 Million |
| Operating Expenses | 68.27 Million | 77.5 Million | 304.74 Million | 146.79 Million | 143.51 Million | 130.9 Million |
| Selling, General and Administrative Expenses | 68.27 Million | 77.5 Million | - | 78.21 Million | 80.25 Million | 68.76 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 6.23 Million | 4.77 Million | 17.48 Million | 4.37 Million | 5.52 Million | 2.81 Million |
| Cost and Expenses | 359.12 Million | 336.8 Million | 1.33 Billion | 362.11 Million | 355.73 Million | 276.56 Million |
| Operating Income | 72.02 Million | 62.38 Million | 309.5 Million | 102.04 Million | 78.53 Million | 70.91 Million |
| Interest Expense | 3.09 Million | 3.4 Million | 11.7 Million | 2.63 Million | 2.79 Million | 2.85 Million |
| Income Tax Expense | 18.17 Million | 15.33 Million | 78.65 Million | 25.57 Million | 20.96 Million | 16.78 Million |
| Earnings before Tax | 75.17 Million | 63.74 Million | 315.29 Million | 99.4 Million | 81.26 Million | 70.87 Million |
| Net Income | 63.99 Million | 49.96 Million | 248.53 Million | 71.74 Million | 65.21 Million | 61.6 Million |
| Earnings Per Share Basic | 7.74 | 6.05 | - | 8.68 | 7.89 | 7.46 |
| Earnings Per Share Diluted | 7.74 | 6.05 | - | 8.68 | 7.89 | 7.46 |
| Weighted Average Shares Outstanding | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million | 8.26 Million |
| Gross Margin | 0.33 | 0.35 | 0.37 | 0.53 | 0.51 | 0.58 |
| EBIT Margin | 0.19 | 0.18 | - | 0.24 | 0.21 | 0.24 |
| Profit Margin | 0.15 | 0.13 | 0.15 | 0.16 | 0.15 | 0.18 |
| EBITDA | 82.49 Million | 70.78 Million | - | 110.39 Million | 92.65 Million | 81.69 Million |
| Earnings Before Tax Margin | 0.17 | 0.16 | 0.19 | 0.22 | 0.18 | 0.20 |
PML
002669
WFC-PL
2605
CNK
ACVA